BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,973 | +24.4% | 8,213 | +50.1% | 0.02% | +35.7% |
| Q2 2023 | $249,250 | +12.4% | 5,470 | +0.0% | 0.01% | +16.7% |
| Q1 2023 | $221,848 | -20.8% | 5,469 | -0.5% | 0.01% | -25.0% |
| Q4 2022 | $280,139 | -7.8% | 5,496 | -2.6% | 0.02% | -20.0% |
| Q3 2022 | $304,000 | -17.8% | 5,645 | -2.1% | 0.02% | -25.9% |
| Q2 2022 | $370,000 | -16.9% | 5,766 | +0.5% | 0.03% | -18.2% |
| Q1 2022 | $445,000 | -10.5% | 5,738 | -0.8% | 0.03% | -2.9% |
| Q4 2021 | $497,000 | +8.3% | 5,785 | +1.3% | 0.03% | -10.5% |
| Q3 2021 | $459,000 | -0.6% | 5,709 | -0.5% | 0.04% | +2.7% |
| Q2 2021 | $462,000 | -6.9% | 5,736 | -2.5% | 0.04% | -22.9% |
| Q1 2021 | $496,000 | +5.1% | 5,886 | +0.0% | 0.05% | +4.3% |
| Q4 2020 | $472,000 | +1.9% | 5,885 | +2.2% | 0.05% | -22.0% |
| Q3 2020 | $463,000 | -7.8% | 5,757 | -1.3% | 0.06% | -15.7% |
| Q2 2020 | $502,000 | +7.5% | 5,831 | +1.3% | 0.07% | +6.1% |
| Q1 2020 | $467,000 | +0.4% | 5,756 | +3.6% | 0.07% | +17.9% |
| Q4 2019 | $465,000 | -4.3% | 5,556 | +0.0% | 0.06% | -13.8% |
| Q3 2019 | $486,000 | +8.7% | 5,555 | +1.7% | 0.06% | +3.2% |
| Q2 2019 | $447,000 | +0.7% | 5,461 | +0.0% | 0.06% | -6.0% |
| Q1 2019 | $444,000 | +23.7% | 5,460 | 0.0% | 0.07% | +17.5% |
| Q4 2018 | $359,000 | -14.7% | 5,460 | 0.0% | 0.06% | -12.3% |
| Q3 2018 | $421,000 | +4.5% | 5,460 | +0.0% | 0.06% | -5.8% |
| Q2 2018 | $403,000 | +13.5% | 5,459 | 0.0% | 0.07% | +6.2% |
| Q1 2018 | $355,000 | +0.6% | 5,459 | +0.0% | 0.06% | -3.0% |
| Q4 2017 | $353,000 | +2.9% | 5,458 | 0.0% | 0.07% | -4.3% |
| Q3 2017 | $343,000 | +5.9% | 5,458 | +1.9% | 0.07% | -2.8% |
| Q2 2017 | $324,000 | +20.0% | 5,358 | +3.0% | 0.07% | +7.5% |
| Q1 2017 | $270,000 | +13.9% | 5,202 | -2.7% | 0.07% | +15.5% |
| Q4 2016 | $237,000 | -6.7% | 5,344 | 0.0% | 0.06% | -12.1% |
| Q3 2016 | $254,000 | +8.1% | 5,344 | +2.7% | 0.07% | +3.1% |
| Q2 2016 | $235,000 | +9.8% | 5,202 | 0.0% | 0.06% | +4.9% |
| Q1 2016 | $214,000 | -41.2% | 5,202 | 0.0% | 0.06% | -47.9% |
| Q2 2015 | $364,000 | +2.2% | 5,202 | +0.1% | 0.12% | +1.7% |
| Q1 2015 | $356,000 | -6.6% | 5,195 | 0.0% | 0.12% | -3.4% |
| Q4 2014 | $381,000 | +2.1% | 5,195 | 0.0% | 0.12% | -5.6% |
| Q3 2014 | $373,000 | -0.8% | 5,195 | 0.0% | 0.13% | -1.6% |
| Q2 2014 | $376,000 | -1.6% | 5,195 | 0.0% | 0.13% | -9.9% |
| Q1 2014 | $382,000 | +0.3% | 5,195 | -5.1% | 0.14% | -2.7% |
| Q4 2013 | $381,000 | +5.8% | 5,473 | 0.0% | 0.15% | -13.1% |
| Q3 2013 | $360,000 | -1.4% | 5,473 | +3.8% | 0.17% | -16.4% |
| Q2 2013 | $365,000 | – | 5,273 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |